Jérôme Castandet

Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae

Martin Everett, Nicolas Sprynski, Alicia Coelho et al. · Antimicrobial Agents and Chemotherapy · 2018 · 94 citations · Full text

Activation of the Lysosome‐Associated p61Hck Isoform Triggers the Biogenesis of Podosomes

Céline Cougoule, Sébastien Carreno, Jérôme Castandet et al. · Traffic · 2005 · 92 citations

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

Simon Leiris, Alicia Coelho, Jérôme Castandet et al. · ACS Infectious Diseases · 2018 · 53 citations · Full text

Metallo-β-lactamase Inhibitors, Pharmacotherapy, Antimicrobial Chemotherapy +25

Tyrosine phosphatase MptpA of Mycobacterium tuberculosis inhibits phagocytosis and increases actin polymerization in macrophages

Jérôme Castandet, Jean-François Prost, Pascale Peyron et al. · Research in Microbiology · 2005 · 47 citations

Inflammation, Pulmonary Tuberculosis, Immunology +9

ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>

David T. Davies, Simon Leiris, Nicolas Sprynski et al. · ACS Infectious Diseases · 2020 · 43 citations

Potent Ndm Inhibitor, Microbial Pathogens, Antimicrobial Chemotherapy +24